Neutralizing type I IFN antibodies trigger an IFN-like response in endothelial cells

Journal of Immunology

Volumn 180, Issue 8, 2008, Pages 5250-5256

  Moll, Herwig Peter ^a   Freudenthaler, Harald ^a   Zommer, Anna ^a   Buchberger, Elisabeth ^a   Brostjan, Christine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; IMMUNOGLOBULIN F(AB) FRAGMENT; INTERFERON ALPHA MONOCLONAL ANTIBODY; INTERFERON ANTIBODY; INTERFERON RECEPTOR; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT ANTIBODY; RECOMBINANT INTERFERON; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ALPHA BETA INTERFERON RECEPTOR; ANTIBODY; IFNAR1 PROTEIN, HUMAN; INTERFERON; INTERFERON REGULATORY FACTOR 9; IRF9 PROTEIN, HUMAN;

ANTIBODY COMBINING SITE; ARTICLE; AUTOCRINE EFFECT; CELL ACTIVATION; CELL TYPE; CELLULAR IMMUNITY; CONTROLLED STUDY; EFFECTOR CELL; EMBRYO; ENDOTHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INTERFERON PRODUCTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; CULTURE TECHNIQUE; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM;

ANTIBODIES; CELL CULTURE TECHNIQUES; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INTERFERON TYPE I; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; RECEPTOR, INTERFERON ALPHA-BETA;

EID: 45949084969     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.8.5250     Document Type: Article

References (23)

1. Takaoka, A., and H. Yanai. 2006. Interferon signalling network in innate defence. Cell. Microbiol. 8: 907-922.
2. Mitani, Y., A. Takaoka, S. H. Kim, Y. Kato, T. Yokochi, N. Tanaka, and T. Taniguchi. 2001. Cross talk of the interferon-α/β signalling complex with gp130 for effective interleukin-6 signalling. Genes Cells 6: 631-640.
3. Takaoka, A., Y. Mitani, H. Suemori, M. Sato, T. Yokochi, S. Noguchi, N. Tanaka, and T. Taniguchi. 2000. Cross talk between interferon-γ and -α/β signaling components in caveolar membrane domains. Science 288: 2357-2360.
4. + T cell activation. Genes Cells 7: 309-320.
5. Honda, K., T. Mizutani, and T. Taniguchi. 2004. Negative regulation of IFN-α/β signaling by IFN regulatory factor 2 for homeostatic development of dendritic cells. Proc. Natl. Acad. Sci. USA 101: 2416-2421.
6. + dendritic cells in mice deficient for IFN regulatory factor-2. Proc. Natl. Acad. Sci. USA 101: 3909-3914.
7. Selmi, C, A. Lleo, M. Zuin, M. Podda, L. Rossaro, and M. E. Gershwin. 2006. Interferon α and its contribution to autoimmunity. Curr. Opin. Investig. Drugs 7: 451-456.
8. Stewart, T. A. 2003. Neutralizing interferon α as a therapeutic approach to autoimmune diseases. Cytokine Growth Factor Rev. 14: 139-154.
9. Chuntharapai, A., J. Lai, X. Huang, V. Gibbs, K. J. Kim, L. G. Presta, and T. A. Stewart. 2001. Characterization and humanization of a monoclonal antibody that neutralizes human leukocyte interferon: a candidate therapeutic for IDDM and SLE. Cytokine 15: 250-260.
10. Brostjan, C, A. Bayer, A. Zommer, A. Gornikiewicz, S. Roka, T. Benko, R. Yaghubian, R. Jakesz, G. Steger, M. Gnant, et al. 2003. Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapy. Cancer 98: 2291-2301.
11. Wang, X., and B. Seed. 2003. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res. 31: e154.
12. Brostjan, C, T. Bellón, Y. Sobanov, M. López-Botet, and E. Hofer. 2002. Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones. J. Immunol. Methods 264: 109-119.
13. Brostjan, C, J. Anrather, V. Csizmadia, G. Natarajan, and H. Winkler. 1997. Glucocorticoids inhibit E-selectin expression by targeting NF-κB and not ATF /c-Jun. J. Immunol. 158: 3836-3844.
14. Brostjan, C, J. Anrather, V. Csizmadia, D. Stroka, M. Soares, F. H. Bach, and H. Winkler. 1996. Glucocorticoid-mediated repression of NF-κB activity in endothelial cells does not involve induction of IκBα synthesis. J. Biol. Chem. 271: 19612-19616.
15. Hernández, J. L., T. Coll, and C. J. Ciudad. 2004. A highly efficient electroporation method for the transfection of endothelial cells. Angiogenesis 7: 235-241.
16. Gottlieb, A. B., S. Masud, R. Ramamurthi, A. Abdulghani, P. Romano, U. Chaudhari, L. T. Dooley, A. A. Fasanmade, and C. L. Wagner. 2003. Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris. J. Am. Acad. Dermatol. 48: 68-75.
17. Margolin, K., M. S. Gordon, E. Holmgren, J. Gaudreault, W. Novotny, G. Fyfe, D. Adelman, S. Stalter, and J. Breed. 2001. Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data. J. Clin. Oncol. 19: 851-856.
18. Erlandsson, L., R. Blumenthal, M. L. Eloranta, H. Engel, G. Alm, S. Weiss, and T. Leanderson. 1998. Interferon-β is required for interferon-α production in mouse fibroblasts. Curr. Biol. 8: 223-226.
19. Lagos, D., M. W. Trotter, R. J. Vart, H. W. Wang, N. C. Matthews, A. Hansen, O. Flore, F. Gotch, and C. Boshoff. 2007. Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells. Blood 109: 1550-1558.
20. Devaraj, S., B. Davis, S. I. Simon, and I. Jialal. 2006. CRP promotes monocyteendothelial cell adhesion via Fcγ receptors in human aortic endothelial cells under static and shear flow conditions. Am. J. Physiol. 291: H1170-H1176.
21. Groger, M., G. Sarmay, E. Fiebiger, K. Wolff, and P. Petzelbauer. 1996. Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro. J. Immunol. 156: 1549-1556.
22. Mineo, C, and P. W. Shaul. 2006. Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae. Cardiovasc. Res. 70: 31-41.
23. Ortiz-Stern, A., and C. Rosales. 2003. Cross-talk between Fc receptors and integrins. Immunol. Lett. 90: 137-143.